Ovarian stimulation for in-vitro fertilization/intracytoplasmic sperm injection with gonadotrophins and gonadotrophin-releasing hormone analogues: agonists and antagonists

Ovarian Stimulation ◽

Vitro Fertilization ◽

Releasing Hormone ◽

P-250. The efficacy of the gonadotrophin releasing hormone antagonist Orgalutran® (ganirelix) in women undergoing ovarian stimulation for in-vitro fertilization or intracytoplasmic sperm injection

Human Reproduction ◽

10.1093/humrep/14.suppl_3.266 ◽

1999 ◽

Vol 14 (Suppl_3) ◽

pp. 266-266

Author(s):

A. Obruca ◽

F. Fischl ◽

J. Huber

Keyword(s):

In Vitro Fertilization ◽

Ovarian Stimulation ◽

Vitro Fertilization ◽

Releasing Hormone ◽

Luteal phase and clinical outcome after human menopausal gonadotrophin/gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in-vitro fertilization/intracytoplasmic sperm injection cycles

Human Reproduction ◽

10.1093/humrep/14.6.1426 ◽

1999 ◽

Vol 14 (6) ◽

pp. 1426-1430 ◽

Cited By ~ 40

Author(s):

C. Albano ◽

J. Smitz ◽

H. Tournaye ◽

H. Riethmüller-Winzen ◽

A. Van Steirteghem ◽

...

Keyword(s):

In Vitro Fertilization ◽

Clinical Outcome ◽

Ovarian Stimulation ◽

Luteal Phase ◽

Vitro Fertilization ◽

Releasing Hormone ◽

Human Menopausal Gonadotrophin ◽

Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm injection treatment cycle: impact on ovarian stimulation. A pilot study

Fertility and Sterility ◽

10.1016/j.fertnstert.2011.01.028 ◽

2011 ◽

Vol 95 (5) ◽

pp. 1714-1719.e2 ◽

Cited By ~ 11

Author(s):

Christophe Blockeel ◽

Arianna Riva ◽

Michel De Vos ◽

Patrick Haentjens ◽

Paul Devroey

Keyword(s):

Pilot Study ◽

In Vitro Fertilization ◽

Ovarian Stimulation ◽

Treatment Cycle ◽

Gonadotropin Releasing Hormone ◽

Vitro Fertilization ◽

Releasing Hormone ◽

Injection Treatment

Microdose gonadotrophin releasing hormone agonist (GnRH-A) flare protocol compared with standard long protocol GnRH-A for ovarian stimulation in patients undergoing in vitro fertilization

Fertility and Sterility ◽

10.1016/s0015-0282(02)04150-x ◽

2002 ◽

Vol 78 ◽

pp. S234 ◽

Cited By ~ 1

Author(s):

Simon M Kelly ◽

Imran R Pirwany ◽

Simon J Phillips ◽

Seang Lin Tan

Keyword(s):

In Vitro Fertilization ◽

Ovarian Stimulation ◽

Vitro Fertilization ◽

Releasing Hormone ◽

Gonadotrophin Releasing Hormone ◽

Long Protocol

Reducing the dose of gonadotrophin-releasing hormone agonist on starting ovarian stimulation: effect on ovarian response and in-vitro fertilization outcome

Human Reproduction ◽

10.1093/humrep/13.9.2382 ◽

1998 ◽

Vol 13 (9) ◽

pp. 2382-2385 ◽

Cited By ~ 10

Author(s):

M. Elgendy ◽

M. Afnan ◽

R. Holder ◽

H. Lashen ◽

Y. Afifi ◽

...

Keyword(s):

In Vitro Fertilization ◽

Ovarian Stimulation ◽

Ovarian Response ◽

Vitro Fertilization ◽

Releasing Hormone ◽

How does long-term gonadotrophin-releasing hormone (GnRH) agonist therapy provided before in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) compare with standard IVF/ICSI alone for women with endometriosis?

Cochrane Clinical Answers ◽

10.1002/cca.2912 ◽

2020 ◽

Author(s):

Charalampos Siristatidis

Keyword(s):

In Vitro Fertilization ◽

Gnrh Agonist ◽

Agonist Therapy ◽

Vitro Fertilization ◽

Releasing Hormone ◽

Use of Gonadotrophin Releasing Hormone (GnRH) Antagonist (Cetrotide) during Ovarian Stimulation for in-vitro Fertilization Treatment: Multiple Doses and Single Dose

Journal of Obstetrics and Gynaecology Research ◽

10.1111/j.1447-0756.2001.tb01267.x ◽

2001 ◽

Vol 27 (5) ◽

pp. 261-265 ◽

Cited By ~ 10

Author(s):

Ernest Hung Yu Ng ◽

Pak Chung Ho

Keyword(s):

Single Dose ◽

In Vitro Fertilization ◽

Ovarian Stimulation ◽

Gnrh Antagonist ◽

Vitro Fertilization ◽

Releasing Hormone ◽

Multiple Doses ◽

High dose gonadotrophin-releasing hormone antagonist (ganirelix) may prevent ovarian hyperstimulation syndrome caused by ovarian stimulation for in-vitro fertilization

Human Reproduction ◽

10.1093/humrep/13.3.573 ◽

1998 ◽

Vol 13 (3) ◽

pp. 573-575 ◽

Cited By ~ 25

Author(s):

D. de Jong ◽

N. S. Macklon ◽

B. M. Mannaerts ◽

H. J. Coelingh Bennink ◽

B. C. Fauser

Keyword(s):

In Vitro Fertilization ◽

Ovarian Stimulation ◽

Ovarian Hyperstimulation Syndrome ◽

High Dose ◽

Ovarian Hyperstimulation ◽

Vitro Fertilization ◽

Releasing Hormone ◽

Influence of gonadotrophin-releasing hormone agonist total dose in the ovarian stimulation in the long down-regulation protocol for in-vitro fertilization

Human Reproduction ◽

10.1093/humrep/12.11.2366 ◽

1997 ◽

Vol 12 (11) ◽

pp. 2366-2369 ◽

Cited By ~ 3

Author(s):

C. Alvarez ◽

N. Cremades ◽

N. Blasco ◽

R. Bernabeu

Keyword(s):

In Vitro Fertilization ◽

Total Dose ◽

Ovarian Stimulation ◽

Down Regulation ◽

Vitro Fertilization ◽

Releasing Hormone ◽

Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization*

Human Reproduction ◽

10.1093/humrep/15.1.43 ◽

2000 ◽

Vol 15 (1) ◽

pp. 43-49 ◽

Cited By ~ 43

Author(s):

N.G.M. Beckers ◽

J.S.E. Laven ◽

M.J.C. Eijkemans ◽

B.C.J.M. Fauser

Keyword(s):

In Vitro Fertilization ◽

Ovarian Stimulation ◽

Luteal Phase ◽

Vitro Fertilization ◽

Releasing Hormone ◽